Purpose
to target T-cells against ERV antigens. If true, new host-directed vaccines could be developed to eliminate HIV infected cells.
Grantee
Division
Global Health
Date
APRIL 2012
Region served
GLOBAL
Committed amount
$999,998
Grant topic
HIV
Duration (months)
48
Grantee location
Portland, Oregon, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.